))
EXTENDED: The ‘Chemical Vaccine’ for Long-Lasting Malaria Prevention (with Theresa Shapiro)
Manage episode 386207095 series 3531530
المحتوى المقدم من Johns Hopkins Malaria Research Institute and Johns Hopkins Bloomberg School of Public Health. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Johns Hopkins Malaria Research Institute and Johns Hopkins Bloomberg School of Public Health أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
An old malaria drug gets a new formulation. But how good is it – and will it drive resistance?
In this podcast, we ask:
- What are the limitations of current malaria vaccines?
- What is the concept of long-acting injectable (LAI) drugs?
- What are the clinical and chemical properties of atovaquone that make it suitable for this purpose?
With Theresa Shapiro, Professor, Johns Hopkins School of Medicine and Division Director, Division of Clinical Pharmacology.
About The PodcastThe Johns Hopkins Malaria Minute is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.
65 حلقات
مشاركة
